IMAB•benzinga•
I-Mab's Givastomig Combo Study Accepted For Mini-Oral Presentation At ESMO GI Cancers Congress 2025
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 30, 2025 by benzinga